Perinatal changes of the gastric parietal cells were studied under normal and various experimental conditions. Histologic examination revealed that the parietal cells appeared markedly increased in number from late fetal to early neonatal days. When premature newborn rats were delivered by cesarean section and were nursed by foster mothers for 1 or 2 days, the degree of increase of these cells reached nearly that in the normal neonates. On the other hand, in fetuses retained in utero 1 day beyond the normal gestation, these cells appeared not increased in number. When these postmature fetuses were delivered, the parietal cells turned to increase in number in a degree similar to that in the normal neonates. Milk given to the premature newborn rats caused 6 h later a marked increase in the number of the parietal cells. Milk given to fetuses in utero also caused an increase of these cells. The results suggest that the development of the parietal cells in perinatal rats is accelerated by the intake of milk and that the fetal parietal cells are ready to respond to milk given at least 1 day before birth.

Keywords:
Parietal cell, Fetal, Neonatal, Oral administration
This content is only available via PDF.
© 1979 S. Karger AG, Basel
1979
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.